Back to that theoretical population of 10,000 in the November Lancet review, only five people would experience muscle problems, and just one would have
a serious breakdown of muscle tissue.
Stated differently, 98
of 100 men treated for five years would receive no benefit from the drug, yet they would all be exposed to risk
of its potentially
serious and fatal side effects, such as
muscle breakdown and kidney failure.